Patient-reported outcomes in rheumatoid arthritis
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Rheumatology
Reference40 articles.
1. RAPID3: an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts - similar results to DAS28 and CDAI in clinical trials and clinical care.;Pincus;Rheum Dis Clin North Am,2009
2. Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis.;Barton;Arthritis Care Res (Hoboken),2010
3. Overview of the patient perspective at OMERACT 10: conceptualizing methods for developing patient-reported outcomes.;Kirwan;J Rheumatol,2011
4. RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) clinical trial of certolizumab pegol.;Pincus;Arthritis Care Res (Hoboken),2011
5. RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds.;Pincus;Arthritis Care Res (Hoboken),2010
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Impact of access to treatment on patient‐reported outcomes among rheumatoid arthritis patients with tDMARDs and bDMARDS in two Latin‐American countries: A prospective observational study;Health Science Reports;2023-03
2. L’amélioration des paramètres rapportés par les patients atteints de polyarthrite rhumatoïde traités par sarilumab est indépendante des niveaux cognitifs;Revue du Rhumatisme;2022-12
3. Improvement in patient-reported outcomes in rheumatoid arthritis patients treated with sarilumab is independent of the cognition levels;Joint Bone Spine;2022-10
4. Impact of initial therapy with upadacitinib or adalimumab on achievement of 48-week treatment goals in patients with rheumatoid arthritis: post hoc analysis of SELECT-COMPARE;Rheumatology;2022-08-26
5. Electronic patient-reported outcome measures using mobile health technology in rheumatology: A scoping review;PLOS ONE;2021-07-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3